Advertisement

IIN

IntriCon Corporation

Healthcare

Set alert

Price alert · IIN

All alert types
24.23 0.00 0.00%
As of Apr 24, 2025
24.21 Day range 24.23

52-week range unavailable

Open
24.21
Prev close
24.23
Mkt cap
225.49M
Vol
198.45K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
24.21
High
24.23
Forward P/E
23.09
Beta
1.01
Short ratio
1.46
Inst. own
63.11%
Dividend
0.00
Ex-div date
Sep 11, 2001
Earnings
May 9, 2022
50-d avg
23.95
200-d avg
19.67
1y target
25.00

2Y chart

Chart tools
Interval
IIN two-year price chart12.515.518.421.424.4Nov 21Dec 21Jan 22Mar 22Apr 22May 22

Key statistics

Market cap
225.49M
Enterprise value
211.14M
Trailing P/E
0.00
Forward P/E
23.09
PEG ratio
0.00
Price / sales
1.78
Price / book
2.41
EPS (TTM)
-0.161
Beta
1.01
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-1.17%
Revenue (TTM)
126.50M
Revenue growth
4.10%
Free cash flow
-8.25M
Total cash
20.77M
Total debt
6.36M
Return on equity
-1.43%
Shares outstanding
9.30M
Short % of float
1.89%
50-day average
23.95
200-day average
19.67

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 25.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy0
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

May 9, 2022

Expected May 9, 2022. Consensus EPS estimate 0.11.

Earnings history

Financials — quick view

All financials
IIN Revenue — quarterly 33.06M
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
IIN Net income — quarterly -657.00K
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022
IIN EPS — quarterly -0.07
2018-Q2 20182018-Q3 20182018-Q4 20182019-Q1 20192019-Q2 20192019-Q3 20192019-Q4 20192020-Q1 20202020-Q2 20202020-Q3 20202020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 2022

Earnings

IIN recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 9, 2022Mar 1, 20220.00———
Feb 28, 2022Dec 1, 20210.01———
Nov 8, 2021Sep 1, 20210.03———
Aug 9, 2021Jun 1, 20210.08———
May 10, 2021Mar 1, 20210.00———
Feb 25, 2021Dec 1, 20200.02———

Upgrades / downgrades

IIN analyst upgrades and downgrades
DateFirmActionFromTo
May 20, 2020Stifelmain—Buy
May 20, 2020B. Riley FBRmain—Buy
Apr 7, 2020B. Riley FBRmain—Buy
Feb 25, 2020B. Riley FBRmain—Buy
Feb 20, 2020B. Riley FBRmain—Buy
Jan 4, 2019Stifel NicolausmainBuyBuy

About IntriCon Corporation

IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
intricon.com

News

Your note

Sign in to keep a note on IIN — it syncs with the Stock Master app.

Insider holders

IIN insider holders
InsiderRelationLatest transactionDateShares held
GERACI MICHAEL POfficerStock GiftMay 11, 202250,015
GIORDANO NICHOLAS ANTHONYDirectorConversion of Exercise of derivative securityJan 20, 2022114,925
GONSIOR DENNIS LOfficerStock Award(Grant)Feb 14, 202269,861
GORDER MARK STEPHENDirectorConversion of Exercise of derivative securityDec 30, 2021373,709
HUGGENBERGER RAYMOND ODirectorStock Award(Grant)May 3, 202111,154
LONGVAL SCOTTChief Executive OfficerStock Award(Grant)Feb 14, 2022117,990

Institution ownership

IIN institution ownership
Holder% heldSharesValueReported
Gamco Investors Inc8.51%791,95118.90MMar 30, 2022
Beryl Capital Management LLC6.41%596,08714.22MMar 30, 2022
Vanguard Group, Inc. (The)4.24%394,8389.42MMar 30, 2022
Dimensional Fund Advisors LP4.02%373,8158.92MMar 30, 2022
Meros Investment Management, Lp3.42%318,1607.59MMar 30, 2022
Gabelli Funds, LLC3.24%301,5397.19MMar 30, 2022

Fund ownership

IIN fund ownership
Holder% heldSharesValueReported
Mairs & Power Small Cap Fund2.86%266,4636.36MMar 30, 2022
EQ Advisors Trust-1290 VT Gamco Small Company Value Port2.83%263,4004.26MDec 30, 2021
Vanguard Total Stock Market Index Fund2.79%259,5284.20MDec 30, 2021
Franklin Value Investors Trust-Franklin Microcap Value F2.36%219,3773.21MJan 30, 2022
Teton Westwood Mighty Mites Fd2.14%198,6653.21MDec 30, 2021
Vanguard Extended Market Index Fund1.35%125,7382.03MDec 30, 2021
Advertisement